MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans
Strategies to enhance the induction of high magnitude T cell responses through vaccination are urgently needed. Major histocompatibility complex (MHC) class II–associated invariant chain (Ii) plays a critical role in antigen presentation, forming MHC class II peptide complexes for the generation of...
Principais autores: | Esposito, I, Cicconi, P, D'Alise, AM, Brown, A, Esposito, M, Swadling, L, Holst, PJ, Bassi, MR, Stornaiuolo, M, Mori, F, Vassilev, V, Li, W, Donnison, T, Gentile, C, Turner, B, von Delft, A, Del Sorbo, M, Barra, F, Contino, AM, Abbate, A, Novellino, E, Thomsen, AR, Christensen, JP, Lahm, A, Grazioli, F, Ammendola, V, Siani, L, Colloca, S, Klenerman, P, Nicosia, A, Dorrell, L, Folgori, A, Capone, S, Barnes, E |
---|---|
Outros Autores: | PEACHI Consortium |
Formato: | Journal article |
Idioma: | English |
Publicado em: |
American Association for the Advancement of Science
2020
|
Registros relacionados
-
Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans
por: Kelly, C, et al.
Publicado em: (2016) -
Chronic Hepatitis C Virus infection subverts vaccine induced T-cell immunity in humans.
por: Kelly, C, et al.
Publicado em: (2016) -
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
por: Swadling, L, et al.
Publicado em: (2014) -
Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates
por: Angiolo Pierantoni, et al.
Publicado em: (2015-01-01) -
Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
por: Capone, S, et al.
Publicado em: (2010)